The Clintons Criticize Companies That Have Donated to Their Foundation
Hillary Clinton rails against big businesses’ taking advantage of corporate tax loopholes in her stump speeches. But despite a barrage of attack lines on the campaign trail, some of the same companies she has criticized are longtime donors to the Bill, Hillary and Chelsea Clinton Foundation .
Michaels and Hess Slide, Teva and JetBlue Trade Higher
Michaels, Hess and AAR skid, Teva Pharmaceutical Industries and JetBlue Airways rise
Markets Right Now: US Stock Indexes Edge Mostly Higher
US stocks end mostly higher on Wall Street as a three-day rally loses steam
Pfizer Calls Off $152B Merger With Allergan
The drug companies terminated the deal days after the Treasury Department instituted new rules on so-called inversions.
Jonah Ray and Kumail Nanjiani Visit Marvel LIVE! at San Diego Comic-Con 2015
Loud and welcome back to marvel live from San Diego comic con 2015. Brett Cuba are featured back from that marble. I'm crazy host and writer have marvels electric giant man. They hear this and we have the very special pleasure of being with two mill in June tell us what. Goodness you're here
New Study Finds Botox May Have Long-Term Skin Benefits
After 4 months, 43 women who received Botox injections saw a significant improvement in their skin's elasticity.
Drugmaker Purchase Part of Wave of Corporate Mergers
Morning Money Memo… Two new takeover deals on Wall Street are just the latest examples of a wave of big corporate mergers. Many large companies recently have gone on a buying spree, taking advantage of soaring stock prices and cheap debt to make takeover bids....
Botox-Maker Finds its Suitor
I'm down Cutler and new York and as a financial markets closed that while its report today Monday November 17. This is story stock a long. Ron out saga on Wall Street has finally come to an end. After several offers and one hostile bid Botox maker Allergan found the suitor it wanted an act paid
$47 Billion Offered to Take Over Botox Maker Allergan
Activist investor Bill Ackman and Valeant Pharmaceuticals unveil bid to purchase the Botox manufacturer